"GLOW-70" and "GLOW 70 mg" identify the same 70 mg blend in a 50/10/10 ratio of GHK-Cu/BPC-157/TB-4
Because participants are followed for several years, results arent expected anytime soon
Keep unmixed vials cool and away from light.
Results and Discussion Intranasal GHK-Cu peptide improved cognitive performance in transgenic 5xFAD mice This study showed that transgenic 5xFAD mice of both sexes exhibited improved cognitive performance after 8 weeks of intranasal GHK-Cu treatment, compared to intranasal saline treated transgenic mice
TB-500 represents an intriguing area of emerging clinical application for long COVID patients dealing with any of the following concerns: Neurological symptoms Cognitive impairment Tissue damage associated with prolonged inflammation KPV and Immune-Gut Axis Modulation KPV is a tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH) with potent anti-inflammatory effects, particularly in the gut
The name reflects the context of its discovery, not a confirmed action in humans in the literature, DSIP remains a subject of research, and its mechanism has not been unambiguously explained (there is no clearly identified receptor)